These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12372239)

  • 1. [Pharmacokinetic and pharmacodynamic concepts for an interpretative reading of the antibiogram].
    Soriano F
    Enferm Infecc Microbiol Clin; 2002 Oct; 20(8):407-11; quiz 412. PubMed ID: 12372239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetic and pharmacodynamic aspects of interpretive reading of the antibiogram].
    Soriano-García F
    Enferm Infecc Microbiol Clin; 2010; 28(7):461-6. PubMed ID: 20381925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interpretive reading of the antibiogram: Intellectual exercise or clinical need?].
    Cantón Moreno R
    Enferm Infecc Microbiol Clin; 2002 Apr; 20(4):176-85; quiz 186, 190. PubMed ID: 11996706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of antimicrobial drugs.
    Levison ME
    Infect Dis Clin North Am; 2004 Sep; 18(3):451-65, vii. PubMed ID: 15308272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial Pharmacokinetics and Pharmacodynamics.
    Jarrell AS; Kruer RM; Johnson D; Lipsett PA
    Surg Infect (Larchmt); 2015 Aug; 16(4):375-9. PubMed ID: 26207398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of antibacterial drugs.
    Levison ME
    Infect Dis Clin North Am; 2000 Jun; 14(2):281-91, vii. PubMed ID: 10829256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].
    Isla A; Canut A; Rodríguez-Gascón A; Labora A; Ardanza-Trevijano B; Solinís MA; Pedraz JL
    Enferm Infecc Microbiol Clin; 2005 Mar; 23(3):116-21. PubMed ID: 15757581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antimicrobial susceptibility testing of bacteria isolated from animals: considerations concerning the predefinition of breakpoints from the clinical pharmacological viewpoint].
    Kietzmann M; Böttner A; Hafez HM; Kehrenberg C; Klarmann D; Krabisch P; Kühn T; Luhofer G; Richter A; Schwarz S; Traeder W; Waldmann KH; Wallmann J; Werckenthin C; ;
    Berl Munch Tierarztl Wochenschr; 2004; 117(3-4):81-7. PubMed ID: 15046455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monitoring of antibiotic treatment of patient with a severe bacterial infection].
    Aubert G; Carricajo A
    Ann Fr Anesth Reanim; 2004 Jul; 23(7):704-13. PubMed ID: 15324959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between pharmacokinetics, pharmacodynamics and efficacy of antibacterial agents in animal models.
    Dalhoff A; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):479-87. PubMed ID: 2226476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'.
    Drusano GL
    Nat Rev Microbiol; 2004 Apr; 2(4):289-300. PubMed ID: 15031728
    [No Abstract]   [Full Text] [Related]  

  • 14. [Microbial resistance to antibiotics from the clinical viewpoint. Paradoxical therapy failures and the significance of pharmacokinetic-pharmacodynamic interactions in vivo].
    Rossi M; Gerber AU
    Ther Umsch; 2002 Jan; 59(1):11-9. PubMed ID: 11851041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial resistance and pharmacodynamics as the basis for prescribing antibiotics in respiratory infections].
    Aguado-García JM; Martín-Herrero JE; Lumbreras-Bermejo C
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):230-7. PubMed ID: 15056440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective.
    Mouton JW; Ambrose PG; Canton R; Drusano GL; Harbarth S; MacGowan A; Theuretzbacher U; Turnidge J
    Drug Resist Updat; 2011 Apr; 14(2):107-17. PubMed ID: 21440486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antimicrobial susceptibility cumulative reports].
    Canut-Blasco A; Calvo J; Rodríguez-Díaz JC; Martínez-Martínez L
    Enferm Infecc Microbiol Clin; 2016 Oct; 34(8):524-30. PubMed ID: 25962661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics/Pharmacodynamics for critical care clinicians.
    Quintiliani R; Quintiliani R
    Crit Care Clin; 2008 Apr; 24(2):335-48, xi. PubMed ID: 18361949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients].
    Garzón JR; Cuervo M S; Gómez R J; Cortés JA
    Rev Chilena Infectol; 2011 Dec; 28(6):537-45. PubMed ID: 22286676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.